Skip to content

The effect of a periodontal intervention on renal health in Aboriginal Australian adults with kidney disease

The effect of a periodontal intervention on renal health in Aboriginal Australian adults with kidney disease

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12614001183673
Acronym
n/a
Enrollment
600
Registered
2014-11-11
Start date
2015-04-06
Completion date
2017-09-01
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The primary purpose of the study is to determine if comprehensive periodontal treatment reduces progression of kidney disease among Aboriginal Australians living in Central Australia with kidney disease. The study hypothesis is that periodontal treatment will reduce progression of kidney disease. Kidney disease is a growing public health concern in Australia, especially among Aboriginal populations. Kidney disease consumes disproportionate healthcare resources and is the most common cause of hospitalisation among Aboriginal Australians. In spite of the unacceptably high social, medical and financial burden caused by kidney disease, there have been few RCTs that explore the impact of treatment to address key risk factors, such as periodontal disease, on, kidney disease progression . As a consequence, the management armamentarium currently available to slow the kidney disease progression is extremely limited and only partially effective.

Interventions

Periodontal treatment, including scaling, root planing and extraction of teeth considered unable to be saved. Sessions will take between 30 to 60 minutes and will occur at three time points by a registered dental professional. The time points will be baseline, 1 month and 2 months (that is, each session separated by a month)

Sponsors

University of Adelaide
Lead SponsorUniversity

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Aboriginal adults living in Central Australia with chronic kidney disease

Exclusion criteria

Unable to sign informed consent form

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026